Vigmed AB, together with its distribution partners, wins tenders in France and Sweden

Vigmed AB, together with its distribution partners, have won important exclusive tenders in France and Sweden.

The tender in Sweden is for CLiP® Ported and CLiP® Winged products to Region Jämtland during a four year tender period.

The tender in France is for SWiTCH products to various hospitals in Paris during a four year tender period.

“We are delighted to communicate regarding won tenders. We know that our products have high quality and to win tenders is additional confirmation that our customers have the same perception. The annual value to Vigmed of these tenders amount to kSEK 400-500 ”, says CEO Henrik Olsen.  

Helsingborg, December 21, 2016
Vigmed Holding AB (publ)

For further information contact:
CEO Henrik Olsen, +46 763-497 364

This information is information that Vigmed Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 14.00 am CET on December 21, 2016.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website:  www.vigmed.com/investor

Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links